Correvio Pharma

View All

Pharma News
Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million. More than decade old Life Sciences-based investment firm specialized in direct secondary transactions, Omega funds focuses in investing in Life Sciences vertical, aiming to fulfil the ...

Find More